BML, Inc. (TYO:4694)

Market Cap	111.48B
Revenue (ttm)	141.33B
Net Income (ttm)	6.08B
Shares Out	39.01M
EPS (ttm)	155.98
PE Ratio	18.32
Forward PE	18.99
Dividend	140.00 (4.94%)
Ex-Dividend Date	Mar 28, 2025

Volume	71,600
Average Volume	49,435
Open	2,816.00
Previous Close	2,832.00
Day's Range	2,808.00 - 2,848.00
52-Week Range	2,592.00 - 3,125.00
Beta	0.22
RSI	50.76
Earnings Date	May 9, 2025

About BML, Inc.

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1955
• Employees: 4,513
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4694

Financial Performance

In 2023, BML, Inc.'s revenue was 137.96 billion, a decrease of -13.48% compared to the previous year's 159.46 billion. Earnings were 6.03 billion, a decrease of -61.27%.